4-oxo-2-nonenal has been researched along with propidium in 1 studies
Studies (4-oxo-2-nonenal) | Trials (4-oxo-2-nonenal) | Recent Studies (post-2010) (4-oxo-2-nonenal) | Studies (propidium) | Trials (propidium) | Recent Studies (post-2010) (propidium) |
---|---|---|---|---|---|
94 | 0 | 47 | 2,877 | 10 | 934 |
Protein | Taxonomy | 4-oxo-2-nonenal (IC50) | propidium (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 6.289 | |
Acetylcholinesterase | Homo sapiens (human) | 6.289 | |
Acetylcholinesterase | Bos taurus (cattle) | 6.289 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chikazawa, M; Matsuda, T; Otaki, N; Shibata, T; Uchida, K; Yasueda, T | 1 |
1 other study(ies) available for 4-oxo-2-nonenal and propidium
Article | Year |
---|---|
An apoptosis-associated mammary protein deficiency leads to enhanced production of IgM antibodies against multiple damage-associated molecules.
Topics: Aldehydes; Animals; Annexin A5; Antibody Formation; Antibody Specificity; Antigens, Surface; Apoptosis; Epitopes; Humans; Immunoglobulin M; Jurkat Cells; Lipid Peroxidation; Mice; Milk Proteins; Oxidation-Reduction; Phagocytosis; Propidium | 2013 |